Overall, we have demonstrated the effectiveness of a BAFF ligand-based CAR-T cells, generated using non-viral methods, in killing ALL, MCL, and MM cells in vitro and in vivo. The gene discussed is TNFSF13B; the disease is acute lymphoblastic leukemia.